Conference abstract · 24 Sep 2012
Conference abstractPublished 24 Sep 2012
Developmental Pharmacokinetics
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Physiological differences between children and adults result in age-related differences in pharmacokinetics and drug effect. The advances in developmental pharmacokinetics during the past decade lead to enhanced understanding of the influence of growth and development on pharmacokinetics. Understanding the role of ontogeny in the disposition and actions of drugs is essential for safe and effective paediatric pharmacotherapeutics. The maturation process involves continuous growth, differentiation, and development of the organs. Developmental changes in physiology and, consequently, in pharmacology influence the efficacy, toxicity, and dosing regimen of drugs. The most dramatic changes occur in excretory organs (liver and kidney) during the first days to months of life which has greatest impact on drug disposition. Gastrointestinal function changes rapidly during the first few days after birth affecting absorption of orally administered drugs. As body composition changes with development, the distribution volumes of drugs are also changes. Levels of plasma proteins also vary in children which also has impact on volume of distribution. Failure to take these factors into account may result in ineffective treatment or severe, unexpected toxicity. Pediatric drug dosage regimens should take into account the age or developmental state of the child and the disease state, rather than simply scaling an adult dose based on body weight or surface area. Ideally, pharmacokinetic and pharmacodynamic data should be available for all drugs used in children. Fatal adverse effects could be avoided by performing clinical trials in paediatric population during the drug development process before the widespread use of drugs in children.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Perspective · 2 Jul 2025
Mitochondrial DNA Heteroplasmy and Its Association With Embryo Developmental Variability in Assisted Reproductive Cycles
Opinion · 2 Jul 2025
Follicular Vascular Remodeling and Its Relationship with Oocyte Developmental Competence in Assisted Reproductive Cycles
Editorial · 31 Mar 2025
Developmental Origins of Health and Disease (DOHaD): Understanding the Lifelong Impact of Early Life Exposures
Conference abstract · 14 Mar 2024
Exploring the relevance and considerations of implementing alternative approaches to the assessment of reproductive and developmental toxicity of pharmaceuticals under ICH S5(R3)
More from this journal
The newest in Gynecology & Obstetrics.
Short communication · 30 Apr 2026
Vitamin D and Polycystic Ovary Syndrome: A Research Progress Review
Conference abstract · 19 Nov 2025
Loss of lncRNAs 1700101O22Rik and 1700027A15Rik causes sperm malformation and subfertility
Conference abstract · 19 Nov 2025
Linking Mitochondrial Fatty Acid Metabolism to Follicular Health: A Novel Perspective on Premature Ovarian Insufficiency
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalGynecology & Obstetrics
- SubjectReproductive Medicine & Gynaecology
- BylineArticles whose byline prints “Mukta N. Chowta”

